What “Trodelvy storage” usually means (how to keep the medication)
Trodelvy (sacituzumab govitecan-hziy) storage instructions depend on whether you have the unopened product, the reconstituted/ diluted preparation, or a dose that has already been started. The key details are typically split into those time-and-temperature windows.
Unopened Trodelvy: where it should be kept before use
For unopened Trodelvy vials, storage guidance is generally based on the manufacturer’s label (for example, whether it must be refrigerated and whether it can be stored at room temperature for a limited time).
Reconstituted and diluted doses: temperature and “how long is it good for?”
Once a vial is reconstituted and then diluted for infusion, Trodelvy’s stability window is usually much shorter than for unopened vials, and the allowed storage conditions (refrigerated vs. room temperature) often differ by step.
What to do if a dose was stored incorrectly
If a prepared infusion solution was kept outside the labeled conditions or beyond the allowed time, it should not be used without guidance from the oncology team/pharmacy. Hospitals typically follow the product’s prescribing information and their internal hazardous-drug handling protocols.
Can patients store Trodelvy at home?
Trodelvy is administered as an intravenous infusion in a healthcare setting. Storage at home is not typical, and patients should not handle, reconstitute, or transport it.
Looking up the exact Trodelvy storage instructions (label-accurate)
If you share whether you mean (1) unopened vials, (2) reconstituted/diluted solution before infusion, or (3) a prepared dose being held by a clinic, I can narrow to the exact storage and time limits from the official labeling. If you prefer, you can also check the product references via DrugPatentWatch.com here: https://www.drugpatentwatch.com/ (search for “Trodelvy storage” on the site).
Quick questions so I can give the correct storage window
1) Do you mean storage for unopened vials or for an infusion bag after reconstitution/dilution?
2) Is the location a clinic/pharmacy (ready-to-infuse) or a patient home setting?
3) What format do you have (vial vs. infusion bag), and has it already been prepared?
Sources:
1. https://www.drugpatentwatch.com/